Skip to content

Application of exercise prescription in the management of childhood asthma

Application of exercise prescription in the management of childhood asthma

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035926
Enrollment
Unknown
Registered
2020-08-20
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

childhood asthma

Interventions

exercise group:standard anti-asthma medication + exercise prescription
control group:standard anti-asthma medication

Sponsors

Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: (1) Diagnosed as bronchial asthma (the diagnostic criteria refer to ''guidelines for diagnosis and Prevention of Bronchial Asthma in Children'', 2016 edition); (2) Aged 6 to 12 years; (3) The guardian of the subject agrees and signs the informed consent.

Exclusion criteria

Exclusion criteria: (1) In the acute attack stage of asthma; (2) Standard anti-asthma treatment less than 3 months; (3) Those who have regular exercise habits; (4) Other systemic chronic diseases; (5) Those whom the investigator considers unsuitable to participate in the clinical trial.

Design outcomes

Primary

MeasureTime frame
Asthma Control Test (C-ACT);Pediatric Asthma Quality of Life Questionnaire (PAQLQ);pulmonary function;

Secondary

MeasureTime frame
fractional exhaled nitric oxide (FeNO);maximal oxygen uptake (VO2max);maximum aerobic power (MAP);O2 pulse;maximal heart rate (HRmax);maximal blood pressure (BPmax);

Countries

China

Contacts

Public ContactLiu Haipei

Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

hpliu@126.com+86 13761692722

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026